Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%

- Check36 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.1%

- Check50 days agoChange DetectedUpdated the page version from v3.0.1 to v3.0.2 and removed the Back to Top element.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of specific medical terms related to Parkinson's disease and immunotherapy. Notably, previous mentions of various drug categories and specific agents have been removed.SummaryDifference2%

- Check79 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.